11Jul 2022
Predictors of Time in Target Glucose Range in Real‐world users of the MiniMed™ 780G System

Predictors of Time in Target Glucose Range in Real‐world users of the MiniMed™ 780G System

Automated insulin delivery use has improved glycaemic control in people with type 1 diabetes mellitus. The analysis investigated predictors of improved sensor glucose (SG) time‐in‐range (TIR; 70–180 mg/dL) based on real‐world use of the MiniMed™ 780G advanced hybrid closed‐loop (AHCL) system. 12,870 users were included, of which 2,977 had baseline SG data. Baseline TIR and time in AHCL were positively associated with TIR post‐AHCL with larger values predicting greater mean TIR post‐AHCL. Modifiable factors including optimised pump settings can allow users to achieve glycaemic targets with >80% TIR. The findings from this analysis will potentially guide the optimal use of the MiniMed™ 780G system and facilitate meaningful improvements in safe glycaemic control.

  • #endo-diabetology

Like

Save

Share